Search

everythinglearnresearchcommunity

for

Search:↓

Chitosan slows root hair growth and causes a buildup of callose at low concentrations, but at high concentrations, it only inhibits growth without callose buildup.

FOXC1 boosts SFRP1 in hair loss, suggesting new treatments.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

CDP is crucial for lung and hair follicle cell development.

AXR3 and SHY2 genes control the growth and timing of root hair development in plants.

Eating less sugar, milk, and saturated fats and more vegetables and fish may help treat and prevent acne.

Male pattern baldness involves hormones and cell signals affecting hair growth.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Potassium channel openers are effective in treating heart conditions, high blood pressure, pulmonary diseases, bladder issues, and hair loss, but more selective drugs are needed.

Cepharanthine and Trifluoperazine are effective against SARS-CoV-2.

The document concludes that certain genetic mutations and dietary factors are involved in acne development, and treatments like isotretinoin and diet changes can help manage it.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

Beta-catenin is crucial for skin cell growth, development, and cancer formation.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

Most Hairless gene mutations reduce its ability to work with the Vitamin D Receptor, which might explain a certain type of hair loss.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

Androgens may block hair growth signals, targeting this could treat hair loss.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Non-viral vectors show promise for safe and effective CRISPR/Cas9 gene editing in treating diseases.

Low vitamin D receptor levels found in hair loss patients; topical vitamin D treatment suggested.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.